AUTH/3851/11/23 - Complainant v Roche

Alleged lack of declaration of Roche’s involvement in a national ophthalmology database audit on Age-related macular degeneration (AMD)

  • Received
    13 November 2023
  • Case number
    AUTH/3851/11/23
  • Applicable Code year
    2021
  • Completed
    10 February 2025
  • No breach Clause(s)
  • Breach Clause(s)
  • Sanctions applied
    Undertaking received
  • Additional sanctions
  • Appeal
    No appeal

Case Summary

This case was in relation to two published reports which had been funded by Roche. The complainant alleged that the first report, a full annual audit report on Age-related Macular Degeneration (AMD), did not declare Roche’s funding at the beginning of the report. The complainant alleged that the second report, a patient summary of the full annual audit report on AMD, did not declare Roche’s funding at all.


The outcome under the 2021 Code was: 

 

Breach of Clause 5.5

Failing to make sufficiently clear as to the company’s role and involvement

Breach of Clause 23.2

Failing to include, in the written agreement for a donation or grant, a statement that all parties are fully aware that the donation or grant must be clearly acknowledged and apparent from the start

 

No Breach of Clause 2

Requirement that activities or materials must not bring discredit upon, or reduce confidence in, the pharmaceutical industry

No Breach of Clause 5.1

Requirement to maintain high standards at all times

No Breach of Clause 5.5

Requirement to be sufficiently clear as to the company’s role and involvement

 

This summary is not intended to be read in isolation.
For full details, please see the full case report below.